An Open Label Treatment Extension Study of AMG 706
NCT00360867
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
94
Enrollment
INDUSTRY
Sponsor class
Stopped
Amgen decision
Conditions
Solid Tumors
Interventions
DRUG:
AMG 706
Sponsor
Amgen